← FDA Drug Approvals (Drugs@FDA)

NALMEFENE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHENGDU SHUODE · Approved 2023-11-15

Drug application

FDA Application #

ANDA216007

Application type

Abbreviated New Drug Application (Generic)

Brand name

NALMEFENE HYDROCHLORIDE

Generic name

NALMEFENE HYDROCHLORIDE INJECTION

Active ingredients

NALMEFENE HYDROCHLORIDE

Dosage form

SOLUTION

Route

INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

Marketing status

Prescription

Sponsor

CHENGDU SHUODE

Manufacturer

Chengdu Shuode Pharmaceutical Co., Ltd

First approval

2023-11-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown